Leena Prasad

Title: Leena Prasad: Innovator in Calcilytic Compounds

Introduction

Leena Prasad is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for treating autosomal dominant hypocalcemia (ADH). Her innovative work has led to the creation of a unique tablet formulation that includes a triphenyl calcilytic compound.

Latest Patents

Leena Prasad holds 1 patent for her work on formulations of triphenyl calcilytic compounds. The patent details a tablet formulation that includes a triphenyl calcilytic compound, which is essential for the treatment of ADH. The compound is represented by a specific formula and may include a solvate, a hydrate, a pharmaceutically acceptable salt, or a combination thereof.

Career Highlights

Leena is currently associated with Calcilytix Therapeutics, Inc., where she continues to advance her research and development efforts. Her work is pivotal in addressing medical conditions related to calcium regulation in the body.

Collaborations

Leena collaborates with esteemed colleagues, including Uma Sinha and Ananth Sridhar, who contribute to her research initiatives and help drive innovation within the company.

Conclusion

Leena Prasad's contributions to the field of pharmaceuticals through her innovative formulations highlight her role as a key inventor in the industry. Her work not only advances scientific knowledge but also has the potential to improve patient outcomes in the treatment of hypocalcemia.